LPGA star Charley Hull collapses twice at Evian Championship, forced to withdraw
Golf Channel reported that after a 15-minute medical break, 29-year-old Hull hit her tee shot and then collapsed again. She was then carted off on a medical cart. Broadcast host Richard Kaufman said they had since learned Hull had been suffering from a virus and it all caught up with her.
"Obviously a very unnerving situation for Charley ad her playing partners," said Kaufman.
Hull, currently No. 19 in the world, placed T-12 in her last two starts on the LPGA – both major championships – and finished fourth last week at the KPMG Women's Irish Open.
Hull's best finish at the Evian is a share of third in 2022.
This article originally appeared on Golfweek: Charley Hull collapses twice at Evian Championship, forced to withdraw
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Darwin Nunez twist could have major impact on Alexander Isak transfer to Liverpool
Newcastle's owners could end up indirectly helping Liverpool to sign Alexander Isak. That's because Al-Hilal, the club that is interested in signing Darwin Nunez from the Reds, is majoratively owned by Saudi Arabia's Public Investment Fund — the same group that majoratively owns Newcastle. Nunez could leave Liverpool before the transfer window closes after three underwhelming seasons on Merseyside, and after Napoli dropped its interest several weeks ago due to Nunez's price tag, there are not many top-level European options remaining for the Uruguayan. The riches on offer in Saudi Arabia could appeal to Nunez, and it is reported by The Athletic that Al-Hilal has made the 26-year-old its top striking target after seeing Victor Osimhen move to Galatasaray. READ MORE: Eddie Howe throws Alexander Isak future into fresh doubt amid Liverpool transfer saga READ MORE: Liverpool transfer news LIVE: Alexander Isak bid, Rodrygo agrees terms, Tyler Morton to Lyon Other targets like Benjamin Sesko and Alexander Isak are viewed as less attainable than Nunez, which is why the Saudi Pro League club is now firmly focused on Liverpool's No.9. If Al-Hilal, funded by the PIF, signs Nunez for the Reds' reported $81 million asking price, that could be the difference between Liverpool signing Isak and Liverpool not signing Isak. Meanwhile, Isak is expected to return to Newcastle's training ground today (Monday) after ruling himself out of the pre-season tour of Asia. Isak did not travel across the world with his teammates, with the official reason being that he was carrying a slight injury, but it soon emerged what the real reason for his absence was. Isak remains keen to leave Newcastle — and he could yet get his wish, despite Liverpool seeing a $146 million bid for the player swiftly rejected last week. Despite being set to return to Newcastle's training ground, Isak has been warned by Magpies manager Eddie Howe that he won't be reintegrated before proving that he is ready to give his all for his current club. "You have to earn the right to train with us," Howe said. "We are Newcastle United. The player has a responsibility here to be part of a team and part of a squad - you have to act in the right way. So that is also at play here. "We will make sure that any player does that to earn the right to train with the group. No player can expect to act poorly and train with the group as normal."
Bloomberg
44 minutes ago
- Bloomberg
Ozempic Maker's Plight Shows Managing Markets Counts Too
Ozempic-maker Novo Nordisk A/S saw its shares take a record plunge last week, sending their peak-to-trough collapse to 70% and returning them to levels last seen in 2022. The Danish drug giant's purpose may be to improve people's lives, but investors' shrinking gains from its opening of the anti-obesity market matter too. Novo's blind spot has been failing to see its share price as an asset to manage — and exploit. For years, Novo had a relatively quiet life as one member of an insulin oligopoly alongside US peer Eli Lilly & Co. and France's Sanofi SA. While it wasn't a completely smooth ride — 2016 was dire — Novo has never seen operational and strategic challenges on the scale it's now facing. In developing Ozempic for diabetes and its sibling Wegovy for weight loss, the company suddenly found itself riding a tiger.
Yahoo
an hour ago
- Yahoo
Miyu Yamashita wins Women's British Open, in photos
APTOPIX Britain Golf Women's Open PORTHCAWL, Wales (AP) — Miyu Yamashita of Japan captured her first major title Sunday when she withstood a charge by Charley Hull by not making a bogey until the outcome of the Women's British Open was no longer in doubt. She closed with a 2-under 70 for a two-shot victory. This photo gallery curated by AP photo editors shows photo highlights from the Women's Golf British Open being played at Royal Porthcawl in Wales. ___ AP golf:
